We want to share a case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise to therapy developers.
Key Highlights:
Advanced Infrastructure: Braintree MIC has repurposed its original site to include advanced technologies, significantly reducing manufacturing costs and increasing patient access to life-changing treatments.
- Workforce Upskilling: Retaining and extensively training 78 staff from the previous site owner, the centre ensures high-quality standards in GMP manufacturing processes.
- Quality and Compliance: A robust Pharmaceutical Quality System (PQS) and controlled SOPs guarantee adherence to regulatory standards.
- Data Integrity: Emphasizing best practices to ensure reliable and accurate manufacturing data, the centre successfully upscaled the AAV vector production platform.
- The Braintree MIC is a testament to the transformative power of innovation in GMP manufacturing, poised to make significant contributions to the field of advanced therapies.
Read the full article in this link to learn more about how Braintree MIC is setting new standards in the industry